Form 4 for APVO Aptevo Therapeutics Inc.
Accepted 2022-06-03 00:00:00 ET · period of report 2016-08-03 · accession 0001209191-22-033928 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-03 | 2022-06-01 | APVO | Niederhuber John | Dir | M - OptEx | — | +298 | 1,814 | +20% | — |
| D | 2022-06-03 | 2019-06-14 | APVO | Niederhuber John | Dir | P - Purchase | $0.91 | +714 | 1,516 | +89% | +$649.74 |
| D | 2022-06-03 | 2022-06-01 | APVO | Niederhuber John | Dir | M - OptEx | $0.00 | -298 | 595 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-01 | M | A | 298 | — | 1,814 | D | — | — | (F3) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. |
| 2 | Common | Common Stock | 2019-06-14 | P | A | 714 | $0.91 | 1,516 | D | — | — | (F2) Reflects a 1-for-14 reverse stock split of the Issuer's common stock effective as of March 26, 2020. |
| 3 | Derivative | Restricted Stock Unit | 2022-06-01 | M | D | 298 | $0.00 | 595 | D | — · — to — | 298 Common Stock | (F3) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F4) On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022. |